Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mauro

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Cytometry|September 1, 1983
Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneityL Teodori, D Tirindelli-Danesi, F Mauro, et al.
Tumori|February 28, 1983
Bone marrow involvement at onset of Hodgkin's diseaseG Cimino, A P Anselmo, A M De Luca, et al.
British Journal of Haematology|March 23, 1999
IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemiaD de Totero, G Reato, F Mauro, et al.
Cancer Letters|January 1, 1990
Sequential evaluation of gastric intraluminal prostaglandin E2 release, acid secretion and DNA-flow cytometry in N-methyl-N-nitro-N-nitrosoguanidine gastric carcinogenesis in the ratG Silecchia, A Materia, E Spaziani, et al.
Surgery, Gynecology & Obstetrics|May 1, 1993
The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometryS Stipa, D T Danesi, C Modini, et al.
Andrologia|July 1, 1984
Flow cytometry and sizing for routine andrological analysisM Spano, A Calugi, V Capuano, et al.
Bone Marrow Transplantation|February 1, 1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemiaG Alimena, M R De Cuia, C Mecucci, et al.
Blood|August 12, 2000
Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemiaK Maloum, F Davi, H Merle-Béral, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1982
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)G Papa, F Mandelli, A P Anselmo, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Potential prognostic significance of cytometrically determined DNA abnormality in GI tract human tumorsL Teodori, D Tirindelli-Danesi, E Cordelli, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Cytometry|September 1, 1983
Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneityL Teodori, D Tirindelli-Danesi, F Mauro, et al.
Tumori|February 28, 1983
Bone marrow involvement at onset of Hodgkin's diseaseG Cimino, A P Anselmo, A M De Luca, et al.
British Journal of Haematology|March 23, 1999
IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemiaD de Totero, G Reato, F Mauro, et al.
Cancer Letters|January 1, 1990
Sequential evaluation of gastric intraluminal prostaglandin E2 release, acid secretion and DNA-flow cytometry in N-methyl-N-nitro-N-nitrosoguanidine gastric carcinogenesis in the ratG Silecchia, A Materia, E Spaziani, et al.
Surgery, Gynecology & Obstetrics|May 1, 1993
The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometryS Stipa, D T Danesi, C Modini, et al.
Andrologia|July 1, 1984
Flow cytometry and sizing for routine andrological analysisM Spano, A Calugi, V Capuano, et al.
Bone Marrow Transplantation|February 1, 1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemiaG Alimena, M R De Cuia, C Mecucci, et al.
Blood|August 12, 2000
Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemiaK Maloum, F Davi, H Merle-Béral, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1982
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)G Papa, F Mandelli, A P Anselmo, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Potential prognostic significance of cytometrically determined DNA abnormality in GI tract human tumorsL Teodori, D Tirindelli-Danesi, E Cordelli, et al.
Pageof 16